109 related articles for article (PubMed ID: 14601101)
21. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
22. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O
J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322
[TBL] [Abstract][Full Text] [Related]
23. Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients.
Lesimple T; Neidhard EM; Vignard V; Lefeuvre C; Adamski H; Labarrière N; Carsin A; Monnier D; Collet B; Clapisson G; Birebent B; Philip I; Toujas L; Chokri M; Quillien V
Clin Cancer Res; 2006 Dec; 12(24):7380-8. PubMed ID: 17189411
[TBL] [Abstract][Full Text] [Related]
24. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
26. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
27. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
[TBL] [Abstract][Full Text] [Related]
28. Specific enhanced expression of platelet-derived endothelial cell growth factor in submucosa of human colorectal cancer.
Nozawa T; Enomoto T; Koshida Y; Sato Y; Kuranami M
Dis Colon Rectum; 2004 Dec; 47(12):2093-100. PubMed ID: 15657660
[TBL] [Abstract][Full Text] [Related]
29. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
30. A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model.
Yoneyama S; Okaji Y; Tsuno NH; Kawai K; Yamashita H; Tsuchiya T; Yamada J; Sunami E; Osada T; Kitayama J; Takahashi K; Nagawa H
Eur J Surg Oncol; 2007 Dec; 33(10):1191-8. PubMed ID: 17314028
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cells as vectors for immunotherapy of cancer.
Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.
Yamanaka R; Homma J; Yajima N; Tsuchiya N; Sano M; Kobayashi T; Yoshida S; Abe T; Narita M; Takahashi M; Tanaka R
Clin Cancer Res; 2005 Jun; 11(11):4160-7. PubMed ID: 15930352
[TBL] [Abstract][Full Text] [Related]
33. Circulating vascular endothelial growth factor in cutaneous malignant melanoma.
Pelletier F; Bermont L; Puzenat E; Blanc D; Cairey-Remonnay S; Mougin C; Laurent R; Humbert P; Aubin F
Br J Dermatol; 2005 Apr; 152(4):685-9. PubMed ID: 15840099
[TBL] [Abstract][Full Text] [Related]
34. [Dendrite cell-based cancer vaccines--clinical application].
Svane IM; Berntsen A; Trepiakas R; Pedersen AE
Ugeskr Laeger; 2006 Apr; 168(14):1415-20. PubMed ID: 16584668
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of circulating angiogenic factors in cancer patients.
Poon RT; Fan ST; Wong J
J Clin Oncol; 2001 Feb; 19(4):1207-25. PubMed ID: 11181687
[TBL] [Abstract][Full Text] [Related]
36. The utility of an in vitro angiogenesis score for prognosis assessment in patients with cervical cancer.
Landt S; Heidecke H; Reuter C; Korlach S; Blohmer JU; Lichtenegger W; Heusner T; Stöblen F; Thill M; Barinoff J; Sehouli J; Kümmel S
Anticancer Res; 2011 Aug; 31(8):2645-9. PubMed ID: 21778317
[TBL] [Abstract][Full Text] [Related]
37. Clinical use of dendritic cells for cancer therapy.
Anguille S; Smits EL; Lion E; van Tendeloo VF; Berneman ZN
Lancet Oncol; 2014 Jun; 15(7):e257-67. PubMed ID: 24872109
[TBL] [Abstract][Full Text] [Related]
38. Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: relationship to platelet alpha-granule content and primary activation.
Gonzalez FJ; Rueda A; Sevilla I; Alonso L; Villarreal V; Torres E; Alba E
Int J Biol Markers; 2004; 19(3):221-8. PubMed ID: 15503824
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy of tumor by targeting angiogenesis.
Hou J; Tian L; Wei Y
Sci China C Life Sci; 2004 Dec; 47(6):545-52. PubMed ID: 15620111
[TBL] [Abstract][Full Text] [Related]
40. Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts.
Starlinger P; Alidzanovic L; Schauer D; Brugger P; Sommerfeldt S; Kuehrer I; Schoppmann SF; Gnant M; Brostjan C
Dis Markers; 2011; 31(2):55-65. PubMed ID: 21896999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]